HUM Humana Inc

  1. Stocks
  2. Healthcare
  3. NYSE: HUM

Price (delayed)

$360.27

Market cap

$43.25B

P/E Ratio

38.37

Dividend/share

$3.54

EPS

$9.39

Enterprise value

$52.59B

?
Relative Growth: Rel. Growth: 57
Relative Strength: Rel. Strength: 90
Relative Valuation: Rel. Valuation: 56
Relative Profitability: Rel. Profitability: 35

Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky. As of 2020 Humana had over 20 million members in the U.S., reported a 2019 revenue of ...

Highlights
The revenue has increased by 14% year-on-year and by 6% since the previous quarter
HUM's gross profit is up by 6% year-on-year
HUM's price to earnings (P/E) is 79% higher than its 5-year quarterly average of 21.5 and 75% higher than its last 4 quarters average of 21.9
The EPS has declined by 34% year-on-year and by 4.9% since the previous quarter
Sector: Healthcare
Industry: Healthcare Plans
Website: https://www.humana.com/
Peers: CNC UNH CI MOH

Key stats

What are the main financial stats of HUM

HUM stock price

How has the Humana stock price performed over time
Intraday
-0.12%
1 week
-2.5%
1 month
16.99%
1 year
53.53%
YTD
40.66%
QTD
107.78%

Financial performance

How have Humana's revenue and profit performed over time
Revenue
$137.2B
Gross profit
$19.22B
Operating income
$2.44B
Net income
$1.13B
Gross margin
14%
Net margin
0.8%
HUM's net margin is down by 43% year-on-year and by 11% since the previous quarter
HUM's operating margin is down by 36% year-on-year and by 14% since the previous quarter
The net income has declined by 34% year-on-year and by 4.9% since the previous quarter
The operating income has contracted by 27% YoY and by 10% from the previous quarter

Price vs fundamentals

How does HUM's price correlate with its fundamentals

Growth

What is Humana's growth rate over time

Valuation

What is Humana stock price valuation
HUM P/E details
P/E
38.37
P/B
2.34
P/S
0.32
EV/EBIT
25.87
EV/EBITDA
18.54
EV/Sales
0.38
HUM's price to earnings (P/E) is 79% higher than its 5-year quarterly average of 21.5 and 75% higher than its last 4 quarters average of 21.9
The EPS has declined by 34% year-on-year and by 4.9% since the previous quarter
The price to book (P/B) is 56% higher than the last 4 quarters average of 1.5 but 19% lower than the 5-year quarterly average of 2.9
The equity is up by 5% since the previous quarter and by 4.7% year-on-year
The P/S is 60% above the last 4 quarters average of 0.2 but 36% below the 5-year quarterly average of 0.5
The revenue has increased by 14% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Humana business performance
The return on sales has declined by 38% year-on-year and by 6% since the previous quarter
The return on equity has declined by 38% year-on-year and by 6% since the previous quarter
The company's return on assets fell by 37% YoY and by 8% QoQ
Humana's return on invested capital has decreased by 34% YoY

Dividends

What is HUM's dividend history
Dividend details
DPS
$3.54
Dividend yield
0.98%
Payout ratio
37.7%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Humana financials performed over time
Humana's total assets is 51% more than its total liabilities
HUM's total liabilities is up by 18% since the previous quarter and by 11% year-on-year
The quick ratio has decreased by 14% YoY and by 11% from the previous quarter
HUM's debt is 23% smaller than its equity
HUM's debt is up by 13% since the previous quarter and by 4.5% year-on-year
Humana's debt to equity has increased by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.